pharmaceutical preparation for oral application, method for producing an oral pharmaceutical preparation, tablet preparation for oral application, method for producing a tablet preparation
pharmaceutical preparation of n- [5- (aminosulfonyl) -4-methyl-1,3-thiazol-2-ll] -n-methyl-2- [4- (2-pyridinyl) phenyl] acetamide. the present invention relates to a pharmaceutical preparation for oral administration comprising n- [5- (aminosulfonyl) -4-methyl-1,3-thiazol-2-yl] -n-methyl-2- [4- (2-pyridinyl) ) -phenyl] acetamide or its hydrates and / or solvates, as well as an acid, a method for its production as well as the use of this preparation for the treatment and / or prophylaxis of diseases that are caused by the herpes viruses, in particular diseases that are caused by the herpes simplex viruses.preparação farmacêutica de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-ll]-n-metil-2-[4-(2-piridinil)fenil]acetamida. o presente invento se refere a uma preparação farmacêutica para administração oral compreendendo n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil] acetamida ou seus hidratos e/ou solvatos, bem como um ácido, um método para sua produção bem como o uso desta preparação para o tratamento e/ou profilaxia de doenças que são causadas pelos vírus da herpes, em particular doenças que são causadas pelos vírus da herpes simplex.
